Clinical Trials Sponsored by Vyriad, Inc.
Total 35530 results
-
Vyriad, Inc.TerminatedRecurrent Non-Small Cell Lung CancerUnited States
-
Vyriad, Inc.CompletedMalignant Solid TumourUnited States
-
Vyriad, Inc.Regeneron PharmaceuticalsRecruitingMelanoma | Head and Neck Squamous Cell Carcinoma | Colo-rectal CancerUnited States, Brazil
-
Vyriad, Inc.Mayo ClinicRecruitingSolid Tumor | Non Small Cell Lung Cancer | Neuroendocrine CarcinomaUnited States
-
Vyriad, Inc.Mayo ClinicCompletedUrothelial CarcinomaUnited States
-
Myriad Genetic Laboratories, Inc.Myriad Genetics, Inc.CompletedHereditary CancerUnited States
-
Myriad Therapeutics, Inc.Terminated
-
Myriad Genetic Laboratories, Inc.Completed
-
Myriad Genetic Laboratories, Inc.TerminatedNSCLC | Lung Cancer | Lung AdenocarcinomaUnited States
-
Myriad Genetic Laboratories, Inc.CompletedProstate CancerUnited States
-
UNICANCERMyriad Genetics, Inc.Completed
-
Myriad Genetic Laboratories, Inc.TerminatedProstate CancerUnited States
-
Myriad Genetic Laboratories, Inc.Terminated
-
Myriad Genetic Laboratories, Inc.Recruiting
-
Myriad Genetic Laboratories, Inc.TerminatedColorectal Cancer, MetastaticUnited States
-
BeiGeneMyriad Genetics, Inc.CompletedLocally Advanced or Metastatic Solid TumorsSpain, Australia, United States, United Kingdom
-
Myriad Genetic Laboratories, Inc.CompletedProstate CancerUnited States
-
Myriad Genetic Laboratories, Inc.TerminatedNSCLC | Lung Cancer | NSCLC AdenocarcinomaUnited States
-
Myriad Genetic Laboratories, Inc.WithdrawnEndometriosis | Chronic Pelvic Pain
-
Myriad Genetic Laboratories, Inc.Completed
-
General Oncology, Inc.Myriad Genetics, Inc.RecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Pancreatic Cancer Stage IV | Breast Cancer Stage IV | BRCA1 Mutation | BRCA2 Mutation | Pancreatic Acinar Cell Carcinoma | Metastatic Pancreatic Cancer | Breast Cancer Metastatic | HER2-negative Breast Cancer | Metastatic Pancreatic Ductal Adenocarcinoma and other conditionsUnited States
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.TerminatedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationUnited States, Spain, United Kingdom, Germany, France
-
BeiGeneMyriad Genetic Laboratories, Inc.CompletedSolid TumorsUnited States, Spain, United Kingdom, France, Australia, New Zealand
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.Withdrawn
-
Myriad Genetic Laboratories, Inc.Intermountain Health Care, Inc.Terminated
-
University of PennsylvaniaAstraZeneca; Myriad Genetics, Inc.RecruitingHigh Grade Serous CarcinomaUnited States
-
Myriad Genetic Laboratories, Inc.University of MinnesotaCompletedMajor Depressive Disorder, Bipolar I and Bipolar IIUnited States
-
Dana-Farber Cancer InstituteMyriad Genetics, Inc.Active, not recruitingBreast Cancer | Invasive Breast Cancer | Genetic Testing | in Situ Breast CancerUnited States
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Spain, Belgium, Australia, Israel, Germany, France, United Kingdom, Italy, Canada, New Zealand
-
Myriad Genetic Laboratories, Inc.Carolina Urologic Research CenterCompleted
-
zr Pharma & GmbHFoundation Medicine; Myriad Genetics, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Spain, Canada, Australia, United Kingdom, France
-
M.D. Anderson Cancer CenterMyriad Genetic Laboratories, Inc.Withdrawn
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.Active, not recruiting
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Canada, Denmark, Germany, Italy, Netherlands, Norway, Spain, Argentina, Taiwan, France, Korea, Republic of, Brazil, Japan, Turkey, United Kingdom, Austria, Australia, Israel, Sweden
-
Tesaro, Inc.Myriad Genetics, Inc.; Facing Our Risk of Cancer EmpoweredCompletedOvarian Neoplasms | Ovarian CancerUnited States, Canada
-
Stanford UniversityVarian Medical Systems, Inc.RecruitingAcute Myeloid LeukemiaUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedMetastatic Adenocarcinoma of the Pancreas | Germline BRCA1/2 Mutations andUnited States, France, Italy, Spain, United Kingdom, Belgium, Canada, Germany, Korea, Republic of, Australia, Israel, Netherlands
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Italy, Spain, Belgium, Poland, Canada, Korea, Republic of, Brazil, Czechia, Hungary, Israel, Argentina, Mexico
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRecurrent Platinum Resistant Ovarian CancerUnited States
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
Myriad Genetic Laboratories, Inc.VA Salt Lake City Health Care SystemTerminated
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
Syrian Private UniversityCompletedRheumatic DiseasesSyrian Arab Republic
-
Syrian Private UniversityCompletedDiabetes Mellitus | Diabetes Complications | Hearing LossSyrian Arab Republic
-
Damascus UniversitySt Joseph University, Beirut, Lebanon; Syrian Atomic Energy Agency, Damascus...CompletedImplant Site ReactionLebanon, Syrian Arab Republic
-
Varian Medical SystemsCompletedLocalized Hepatocellular CarcinomaChina
-
Dana-Farber Cancer InstituteTranslational Breast Cancer Research Consortium; Myriad Genetics, Inc.CompletedTriple Negative Breast CancerUnited States
-
Syrian Private UniversityCompletedPeriodontal PocketsSyrian Arab Republic